Specialties: Oncology
ClinicalInterests: Lymphoma
Education:
Dr. Li got herdoctoral degree from Jinan University
Professionalmemberships:
Member of ASH, CACA, Vice Chairman of association of hematologistof Guangzhou and lymphoma division of Guangzhou anti-cancer association
Publications:
1 Chen F, Pang D, Guo H, Ou Q, Wu X, Jiang X, Wei X, Liu S, Huang L, Liang Z, Zhou D, Li W. Clinical outcomes of newlydiagnosed primary CNS lymphoma treated with ibrutinib-based combinationtherapy: A real-world experience of off-label ibrutinib use. Cancer Med.2020;9(22):8676-8684.
2 Chen F, Pang D, Guo H, Jiang X, LiuS, Huang L, Wei X, Liang Z, Wang X, LiW. Clinicopathological Characteristics and Mutational Profiling of AdultT-Cell Lymphoblastic Lymphoma in a Chinese Population. Cancer Manag Res. 2020;12:3003-3012.
3 Chen F, Guo H, Mao C, Jiang X, LiuS, Huang L, Wei X, Liang Z, Zhou D, LiW. Unusual Relapse of Primary Central Nervous System Lymphoma Both Insideand Outside Central Nervous System in Patient with Ventriculoperitoneal Shunt.World Neurosurg. 2019;127:625-628.
4 Mao C#, Chen F#, Li Y#, Jiang X, Liu S, Guo H, Huang L, Wei X, Liang Z, Li W*, Tang K*.Characteristics and Outcomes of Primary Central Nervous System Lymphoma: ARetrospective Study of 91 Cases in a Chinese Population. World Neurosurg. 2019;123:e15-e24.
5 Huang L, Zhang F, Zeng J, Guo H, LiuS, Wei X, Chen F, Jiang X, Liang Z, Liu Y, Li W. ALK expression plays different roles in anaplastic large-celllymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients ina Chinese population. Ann Hematol. 2018;97(1):149-159.
6 Lin GW, Xu C, Chen K, Huang HQ, Chen J, Song B, Chan JKC, Li W, Liu W, Shih LY, Chuang WY, KimWS, Tan W, Peng RJ, Laurensia Y, Cheah DMZ, Huang D, Cheng CL, Su YJ, Tan SY,Ng SB, Tang TPL, Han K, Wang VY, Jia WH, Pei Z, LiYJ, Gao S, Shi Y, Hu Z, ZhangF, Zhang B, Zeng YX, Shen H, He L, Ong CK, Lim ST, Chanock S, Kwong YL, Lin D,Rothman N, Khor CC, Lan Q, Bei JX. Genetic risk of extranodal natural killerT-cell lymphoma: a genome wide association study in multiple populations.Lancet Oncol, 2020,21(2):306-316.
7 Ling Huang，Fen Zhang，Jialong Zeng，Hanguo Guo，Sichu Liu，Xiaojuan Wei，Feili Chen，Xinmiao Jiang，Zhanli Liang，Yanhui Liu，Wenyu Li. ALKexpression plays different roles in anaplastic large-cell lymphomas and outcomeof crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.Ann Hematol, 2018,97:149-159.
8 Kai-lin Chen, Yanhui Liu, Wenyu Li, Jie Chen, Yang-Kui Gu,Qi-Rong Geng, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin, Zhong-Jun Xia,Qing-Qing Cai. The prognostic nutritional index predicts survival for patientswith extranodal natural killer/T cell lymphoma, nasal type. Ann Hematol 2015, 94(8):1389-400.
9 WenyuLi, Ling Huang, Hanguo Guo, Xiaojun Wei, Zhanli Liang.Antiviral efficacy analysis of telbivudine concurrent with the first cycle ofchemotherapy in HBsAg-positive lymphoma patients. J Clin Virol, 2014,61:199-203.
10 Xu Wang, Yan Xu, Lichan Liang, Yi Xu,Chunyan Wang, Liang Wang, Shaohua Chen, Lijian Yang, Xiuli Wu, Bo Li, Gengxin Luo, Huo Tan, Wenyu Li and Yangqiu Li. Abnormalexpression of A20 and its regulated genes in peripheral blood from patientswith Lymphomas. Cancer Cell International 2014, 14, 36:1-6.
11 Xiaomao Hu, Wenyu Li, Gexiu Liu, Hong Wu, Yangjun Gao,Shengting Chen,Dongmei He, Yuan Zhang. The effect of Bcl-2 siRNA combined with miR-15aoligonucleotides on the growth of Raji cells. Med Oncol.2013, 30: 430.IF 2.058
12 Fu Yong-heng, Zhu Jie-ning, Huang shuai,Guo Lin-lin, Lin Qiu-xiong, Zang Meng-zhen, Tan Hong-hong, Kuang Su-juan, YangHui, Fei Hong-wen, Wenyu Li, ShanZhi-xin. MicroRNAs participate in the cardioprotective activity of dexrazoxaneagains doxorubicin-induced cardiotoxicity. S Chin J Cardiol 2012, 13(3):169－180.
